Clinical trial Recruiting at 1 site Observational Ages 19 to 69

Evaluating Korean medicine for treating Bell's palsy

Official title: The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy : A Prospective Observational Preliminary Study

Run by Jaseng Medical Foundation · NCT04905745 · Data updated 2026-11-12

This study is testing if Korean medicine can help adults with Bell's palsy improve their facial function and overall condition over three months.

Quick facts

Study typeObservational
Ages19 Years to 69 Years
SexAll
Enrollment100 (estimated)
SponsorJaseng Medical Foundation
Academic / other
Locations1 site (Seoul, Gangnam-Gu)
StatusRecruiting
StartedMay 25, 2021
Main results expectedAugust 31, 2027
Study endsAugust 31, 2027
Registry record updatedFebruary 25, 2026
Trial IDNCT04905745 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 19 to 69 who have been diagnosed with unilateral peripheral facial nerve palsy within the last three weeks.

Probably not a fit

Patients with central nervous system diseases or those who have received significant prior treatments for facial paralysis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses the effectiveness and safety of Korean integrative treatments in patients diagnosed with peripheral facial nerve palsy. A total of 100 adult participants, aged 19 to 69, will be enrolled and monitored for changes in their condition using the Facial Disability Index (FDI) over a three-month period. The treatment approach will be tailored by experienced clinicians based on individual patient needs, with weekly visits during treatment and follow-up assessments at specified intervals. Data will be collected to evaluate the outcomes of the interventions provided.

Why it matters

Potential benefit: If successful, this study could offer a new effective treatment option for patients suffering from Bell's palsy.

How similar studies have gone: While this approach is relatively novel, other studies have explored integrative medicine for various conditions, showing promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age of 19 to 69
2. diagnosed with unilateral peripheral facial nerve palsy
3. onset of facial palsy within 3 weeks or less.
4. an individual who can provide written consent form to participate in the study.

Exclusion Criteria:

1. diagnosed with central nervous system disease causing facial palsy
2. secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture.
3. Ramsay-Hunt syndrome
4. bilateral or recurrent facial nerve palsy.
5. an individual who received any treatment that can have a significant effect on changes in facial paralysis within recent 2 month. (ie. facial nerve decompression surgery)
6. already or planned to be pregnant or breast-feeding within the study period.
7. uncontrolled diabetes mellitus within the last 3 months.
8. within a month after participating any other facial palsy-related clinical trials, or planning to participate other clinical trials within 6 month.
9. impossible to read and understand the documents, regarding informed consent form and the questionnaires.
10. difficult to participate according to the judgement of researchers.

Where it's running

  • Jaseng Hospital of Korean Medicine
    Seoul, Gangnam-Gu, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.